These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2412009)

  • 1. Natriuretic effect of calcium antagonists.
    Zanchetti A; Leonetti G
    J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S33-7. PubMed ID: 2412009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium entry blockers: antihypertensive and natriuretic effects in experimental animals.
    Nagao T; Yamaguchi I; Narita H; Nakajima H
    Am J Cardiol; 1985 Dec; 56(16):56H-61H. PubMed ID: 3878075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal tubular effects of calcium antagonists.
    Larochelle P
    Kidney Int Suppl; 1992 May; 36():S49-53. PubMed ID: 1614068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of calcium antagonists on electrolytes and water balance in hypertensive patients.
    Leonetti G
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S25-9. PubMed ID: 7603074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natriuretic effects of calcium antagonists. Clinical implications.
    Zanchetti A; Leonetti G
    Drugs; 1990; 40 Suppl 2():15-21. PubMed ID: 2150634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of big endothelin-1-induced diuresis and natriuresis : role of ET(B) receptors.
    Hoffman A; Abassi ZA; Brodsky S; Ramadan R; Winaver J
    Hypertension; 2000 Mar; 35(3):732-9. PubMed ID: 10720587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis.
    Honda M; Hayashi K; Matsuda H; Kubota E; Tokuyama H; Okubo K; Ozawa Y; Saruta T
    Clin Sci (Lond); 2001 Oct; 101(4):421-7. PubMed ID: 11566080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenergic sodium handling and the natriuretic action of calcium antagonists.
    Zanchetti A; Stella A; Golin R
    J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S194-8. PubMed ID: 2414587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium antagonists and the kidney.
    Chellingsworth M; Kendall MJ
    J Hum Hypertens; 1987 Jun; 1(1):3-8. PubMed ID: 3334055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of CS-905, a novel dihydropyridine calcium channel blocker, on arterial pressure, renal excretory function, and inner medullary blood flow in the rat.
    Yagil Y; Miyamoto M; Frasier L; Oizumi K; Koike H
    Am J Hypertens; 1994 Jul; 7(7 Pt 1):637-46. PubMed ID: 7946166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kidney and strategies for the treatment of hypertension.
    Hollenberg NK
    Am J Med; 1984 Oct; 77(4A):60-3. PubMed ID: 6207726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Does the diuretic effect of calcium inhibitors play an important role in the hypertensive efficacy?].
    Maldonado Martin A; Gil Extremera B; Rubio Luengo MA
    Presse Med; 1995 Apr; 24(14):686-90. PubMed ID: 7770417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal hemodynamic and natriuretic effects of atrial natriuretic factor.
    Maack T; Atlas SA; Camargo MJ; Cogan MG
    Fed Proc; 1986 Jun; 45(7):2128-32. PubMed ID: 3011521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal effects of the new calcium channel blocking drug isradipine.
    Krämer BK; Häussler M; Ress KM; Müller GA; Burger KJ; Risler T
    Eur J Clin Pharmacol; 1990; 39(4):333-5. PubMed ID: 2150190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular and renal effects of single administration of three different doses of isradipine in hypertensive patients. Dose-response curves of the different effects.
    Rupoli L; Fruscio M; Gradnik R; Chianca R; Leonetti G; Zanchetti A
    Am J Med; 1989 Apr; 86(4A):65-6. PubMed ID: 2523658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.
    Sánchez RA; Marcó E; Gilbert HB; Raffaele P; Brito M; Giménez M; Moledo LI
    Drugs; 1985; 30 Suppl 1():49-58. PubMed ID: 2994987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal effects of felodipine in hypertension.
    Leonetti G; Terzoli L; Rupoli L; Gradnik R; Zanchetti A
    Drugs; 1987; 34 Suppl 3():59-66. PubMed ID: 3443065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial natriuretic hormones--thirty years after the discovery of atrial volume receptors.
    Kramer HJ; Lichardus B
    Klin Wochenschr; 1986 Aug; 64(16):719-31. PubMed ID: 2945041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of felodipine on natriuresis, atrial natriuretic factor, the renin-angiotensin-aldosterone system, and blood pressure in essential hypertension.
    Cerasola G; Cottone S; Mangano MT; D'Ignoto G; Pinto A; Carone MB
    Clin Ther; 1988; 10(6):694-703. PubMed ID: 2975530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.